108 related articles for article (PubMed ID: 2536954)
21. Epstein-Barr virus infection induces miR-21 in terminally differentiated malignant B cells.
Anastasiadou E; Garg N; Bigi R; Yadav S; Campese AF; Lapenta C; Spada M; Cuomo L; Botta A; Belardelli F; Frati L; Ferretti E; Faggioni A; Trivedi P
Int J Cancer; 2015 Sep; 137(6):1491-7. PubMed ID: 25704079
[TBL] [Abstract][Full Text] [Related]
22. Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras.
MacKenzie KL; Franco S; Naiyer AJ; May C; Sadelain M; Rafii S; Moore MA
Oncogene; 2002 Jun; 21(27):4200-11. PubMed ID: 12082607
[TBL] [Abstract][Full Text] [Related]
23. Increased sensitivity of nontumorigenic fibroblasts expressing ras or myc oncogenes to malignant transformation induced by 5-aza-2'-deoxycytidine.
Rimoldi D; Srikantan V; Wilson VL; Bassin RH; Samid D
Cancer Res; 1991 Jan; 51(1):324-30. PubMed ID: 1703037
[TBL] [Abstract][Full Text] [Related]
24. Precursor B cells transformed by Epstein-Barr virus undergo sterile plasma-cell differentiation: J-chain expression without immunoglobulin.
Kubagawa H; Burrows PD; Grossi CE; Mestecky J; Cooper MD
Proc Natl Acad Sci U S A; 1988 Feb; 85(3):875-9. PubMed ID: 2829207
[TBL] [Abstract][Full Text] [Related]
25. [The characteristics of the transformed phenotype and the expression of indicator plasmids in the cells of rat embryonic fibroblasts immortalized by oncogene E1Aad5 and transformed by oncogenes E1Aad5+c-Ha-ras].
Pospelova TV; Kisliakova TV; Medvedev AV; Svetlikova SB; Pospelov VA
Tsitologiia; 1990; 32(2):148-55. PubMed ID: 2142348
[TBL] [Abstract][Full Text] [Related]
26. Regression of experimental human leukemias and solid tumors induced by Epstein-Barr virus-immortalized B cells.
Angiolillo AL; Sgadari C; Sheikh N; Reaman GH; Tosato G
Leuk Lymphoma; 1995 Oct; 19(3-4):267-76. PubMed ID: 8535218
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the B-cell compartment in plasma cell leukemia and multiple myeloma: immunoglobulin gene rearrangement of EBV-infected B-cell lines.
Commes T; Clofent G; Ghanem N; Zhang XG; Lefranc MP; Bataille R; Klein B
Leukemia; 1993 Apr; 7(4):609-17. PubMed ID: 7681918
[TBL] [Abstract][Full Text] [Related]
28. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
29. Identification of EBV transforming genes by recombinant EBV technology.
Izumi KM
Semin Cancer Biol; 2001 Dec; 11(6):407-14. PubMed ID: 11669602
[TBL] [Abstract][Full Text] [Related]
30. [Studies on transformation of human lymphocytes by Epstein-Barr virus (author's transl)].
Takada K
Hokkaido Igaku Zasshi; 1980 Sep; 55(5):447-70. PubMed ID: 6263773
[TBL] [Abstract][Full Text] [Related]
31. Metabolic stress is a barrier to Epstein-Barr virus-mediated B-cell immortalization.
McFadden K; Hafez AY; Kishton R; Messinger JE; Nikitin PA; Rathmell JC; Luftig MA
Proc Natl Acad Sci U S A; 2016 Feb; 113(6):E782-90. PubMed ID: 26802124
[TBL] [Abstract][Full Text] [Related]
32. Transformation of Epstein-Barr virus immortalized human B-cells by chemical carcinogens.
Kessler DJ; Heilman CA; Cossman J; Maguire RT; Thorgeirsson SS
Cancer Res; 1987 Jan; 47(2):527-31. PubMed ID: 3491677
[TBL] [Abstract][Full Text] [Related]
33. Growth and spread in nude mice of Epstein-Barr virus transformed B-cells from a chronic lymphocytic leukemia patient.
Lee CL; Uniyal S; Fernandez LA; Lee SH; Ghose T
Cancer Res; 1986 May; 46(5):2497-501. PubMed ID: 3008990
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
[TBL] [Abstract][Full Text] [Related]
35. Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses.
Lacoste V; Judde JG; Bestett G; Cadranel J; Antoine M; Valensi F; Delabesse E; Macintyre E; Gessain A
Leuk Lymphoma; 2000 Jul; 38(3-4):401-9. PubMed ID: 10830748
[TBL] [Abstract][Full Text] [Related]
36. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
[TBL] [Abstract][Full Text] [Related]
37. EBV transformation overrides gene expression patterns of B cell differentiation stages.
Siemer D; Kurth J; Lang S; Lehnerdt G; Stanelle J; Küppers R
Mol Immunol; 2008 Jun; 45(11):3133-41. PubMed ID: 18430472
[TBL] [Abstract][Full Text] [Related]
38. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
39. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7.
Parker GA; Crook T; Bain M; Sara EA; Farrell PJ; Allday MJ
Oncogene; 1996 Dec; 13(12):2541-9. PubMed ID: 9000128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
